230 related articles for article (PubMed ID: 2924321)
1. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
Rouah E; Wilson DR; Armstrong DL; Darlington GJ
Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
[TBL] [Abstract][Full Text] [Related]
2. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.
Grady-Leopardi EF; Schwab M; Ablin AR; Rosenau W
Cancer Res; 1986 Jun; 46(6):3196-9. PubMed ID: 2421891
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
6. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
7. Increased N-myc expression following progressive growth of human neuroblastoma.
Rosen N; Reynolds CP; Thiele CJ; Biedler JL; Israel MA
Cancer Res; 1986 Aug; 46(8):4139-42. PubMed ID: 3731081
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
9. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis.
Bjelfman C; Hedborg F; Johansson I; Nordenskjöld M; Påhlman S
Cancer Res; 1990 Nov; 50(21):6908-14. PubMed ID: 1698545
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
11. Importance of phenotypic and molecular characterization for identification of a neuroepithelioma tumor cell line, NUB-20.
Yeger H; Mor O; Pawlin G; Kaplinsky C; Shiloh Y
Cancer Res; 1990 May; 50(9):2794-802. PubMed ID: 2158399
[TBL] [Abstract][Full Text] [Related]
12. Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines.
Whitesell L; Rosolen A; Neckers LM
Prog Clin Biol Res; 1991; 366():45-54. PubMed ID: 2068159
[No Abstract] [Full Text] [Related]
13. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
Raffel C; Gilles FE; Weinberg KI
Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
[TBL] [Abstract][Full Text] [Related]
14. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the N-myc gene in Wilms' tumors.
Nisen PD; Zimmerman KA; Cotter SV; Gilbert F; Alt FW
Cancer Res; 1986 Dec; 46(12 Pt 1):6217-22. PubMed ID: 2430692
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
[TBL] [Abstract][Full Text] [Related]
18. N-myc protein expression in small round cell tumors.
Triche TJ; Cavazzana AO; Navarro S; Reynolds CP; Slamon DJ; Seeger RE
Prog Clin Biol Res; 1988; 271():475-85. PubMed ID: 3406014
[No Abstract] [Full Text] [Related]
19. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus.
Dehner LP
Arch Pathol Lab Med; 1986 Nov; 110(11):997-1005. PubMed ID: 3535732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]